Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.

Autor: Pinto TAM; Clinical Oncology Service, Department of Anesthesiology, Oncology, and Radiology, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Saito HPA; Clinical Oncology Service, Department of Anesthesiology, Oncology, and Radiology, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Nourani CL; Clinical Oncology Service, Department of Anesthesiology, Oncology, and Radiology, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Ataide EC; Department of Surgery, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Boin IFSF; Department of Surgery, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Lourenco GJ; Laboratory of Cancer Genetics; School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil., Lima CSP; Clinical Oncology Service, Department of Anesthesiology, Oncology, and Radiology, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil.; Laboratory of Cancer Genetics; School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil.

Publikováno v: Gastroenterology research [Gastroenterology Res] 2024 Feb; Vol. 17 (1), pp. 23-31. Date of Electronic Publication: 2024 Feb 28.